Pharmacokinetic Evaluation of Mycophenolic Acid Profiles During the Period Immediately Following an Orthotopic Liver Transplant

Transplantation Proceedings

Volumn 38, Issue 8, 2006, Pages 2482-2485

  Fatela Cantillo, D ^a   Hinojosa Perez R ^a   Peralvo Rodriguez M I ^a   Serrano Diaz Canedo J ^a   Gomez Bravo M A ^a  

^a Surgical Hepato Pancreato Biliary Unit   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; DACLIZUMAB; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TSUKUBAENOLIDE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; AUTOIMMUNE HEPATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; FEMALE; HUMAN; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL;

AREA UNDER CURVE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRCULATION; LIVER TRANSPLANTATION; MYCOPHENOLIC ACID; POSTOPERATIVE PERIOD; TIME FACTORS;

EID: 33750620651     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.08.076     Document Type: Article

References (20)

1. Perry I., and Neuberger J. Immunosuppression: towards a logical approach in liver transplantation. Clin Exp Immunol 139 (2005) 2
2. Cantarovich M., Tzinnas G.N., Barkum J., et al. Efficacy of mycophenolate mofetil combined with very low-dose cyclosporine microemulsion in long term liver transplant patients with renal dysfunction. Transplantation 76 (2003) 98
3. Pfitzmann R., Klupp J., Langrehr J.M., et al. Mycophenolate mofetil for immunosuppression after liver transplantation: a follow up study of 191 patients. Transplantation 76 (2003) 130
4. Shaw L.M., Nicholls A., Hale M., et al. Therapeutic drug monitoring of mycophenolic acid: A consensus panel report. Clin Biochem 31 (1998) 317
5. Shaw L.M., Holt D.W., Oellerich M., et al. Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion. Ther Drug Monit 23 (2001) 305
6. Shaw L.M., Pawinski T., Korecka M., et al. Monitoring of mycophenolic acid in clinical transplantation. Ther Drug Monit 24 (2002) 68
7. Mourad M., Wallemacq P., König J., et al. Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients. Is it necessary?. Clin Pharmacokinet 41 (2002) 319
8. Tsunoda S.M., Aweeka F.T., and Drug concentration monitoring of immunosuppressive agents. Focus on tacrolimus, mycophenolate mofetil and sirolimus. BioDrugs 14 (2000) 355
9. Willis C., Taylor P.J., Salm P., et al. Evaluation of limited sampling strategies for estimation of 12-hour mycophenolic acid area under the plasma concentration-time curve in adult renal transplant patients. Ther Drug Monit 22 (2000) 549
10. Pawinski T., Hale M., Korecka M., et al. Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus. Clin Chem 48 (2002) 1497
11. Le Guellec C., Büchler M., Giraudeau B., et al. Simultaneous estimation of cyclosporine and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy. Eur J Clin Pharmacol 57 (2002) 805
12. Schütz E., Armstrong V.W., Shipkova M., et al., German Study Group on MMF Therapy in Pediatric Renal Transplant Recipients. Limited sampling strategy for determination of mycophenolic acid area under the curve in pediatric kidney recipients. Transplant Proc 30 (1998) 1182
13. Filler G., and Mai I. Limited sampling strategy for mycophenolic acid area under the curve. Ther Drug Monit 22 (2000) 169
14. Yeung S., Tong K.L., Tsang W.K., et al. Determination of mycophenolate area under the curve by limited sampling strategy. Transplant Proc 33 (2000) 1052
15. Cox V.C., and Ensom M.H.H. Mycophenolate mofetil for solid organ transplantation: does the evidence support the need for clinical pharmacokinetic monitoring?. Ther Drug Monit 25 (2003) 137
16. Oellerich M., Shipkova M., Schutz E., et al., German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients. Pharmacokinetic and metabolic investigation of mycophenolic acid in pediatric renal transplant recipients implications for therapeutic drug monitoring. Ther Drug Monit 22 (2000) 20
17. Hale M.D., Nicholls A.J., Bullingham R.E.S., et al. The pharmacokinetic-pharmacodinamic relationship for mycophenolate mofetil in renal transplantation. J Clin Pharm Ther 64 (1998) 672
18. Pisupati J., Jain A., Burckart G., et al. Intraindividual and interindividual variations of mycophenolic acid in liver transplant patients. J Clin Pharmacol 45 (2005) 34
19. Atchenson B.A., Taylor P.J., Kirkpatrick C.M., et al. Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia. Ther Drug Monit 26 (2004) 284
20. Mudge D.W., Atchenson B.A., Taylor P.J., et al. Severe toxicity associated with a markedly elevated mycophenolic acid free fraction in a renal transplant recipient. Ther Drug Monit 26 (2004) 453